Company intelligence / Profile preview

Hippocratic AI

Palo Alto, California, United Stateshippocraticai.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hippocratic AI has developed safety-focused large language models specifically for healthcare. Its generative AI agents have achieved safety parity with human clinicians in non-diagnostic roles. The company’s technology has been deployed commercially with multiple health systems, completing hundreds of thousands of patient interactions. No clinical trial results as the company does not develop therapeutics.

Therapeutic areas: Other
Modalities: Not applicable (company develops generative AI agents and large language models for healthcare; not a drug developer)
Industry: Digital Health Medical Devices

Partnerships

Nvidia/NVenturesEUCALIA Inc. (Japan market entry)

Beyond the preview

Go deeper on Hippocratic AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hippocratic AI.

Explore the full profile